Article Details

Seattle's HDT Bio to start US clinical trials of its COVID-19 vaccine candidate

Retrieved on: 2021-07-02 17:48:45

Tags for this article:

Click the tags to see associated articles and topics

Seattle's HDT Bio to start US clinical trials of its COVID-19 vaccine candidate. View article details on hiswai:

Excerpt

The immune system raises a response against the proteins encoded by the RNA, and the nanoparticle boost the response. The company will be ...

Article found on: www.geekwire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo